MedPath

The Impact of Focused Transthoracic Echocardiography in Urgent Abdominal Surgery for Septic Patients

Not Applicable
Completed
Conditions
Sepsis
Peritonitis
Hypovolemia
Interventions
Other: Focused assessed echocardiography
Registration Number
NCT02846948
Lead Sponsor
Lithuanian University of Health Sciences
Brief Summary

The aim of the study is to identify the diagnostic value of the focused assessed echocardiography in septic patients undergoing urgent abdominal surgery due to peritonitis. The investigators expect that the incidence of hemodynamic instability will be reduced and the survival of the patients will be improved.

Detailed Description

Often sepsis remains undiagnosed at the very beginning because of the concentration to the surgical pathology in perioperative period. This results in unacceptably high mortality. The investigators hypothesize that extended hemodynamic monitoring by focused transthoracic echocardiography will personalize early fluid resuscitation which will improve patient's outcome.

The goals of the investigators study are:

* To conduct two-group randomized controlled clinical trial to compare patient management based on standard monitoring and extended hemodynamic monitoring by focused transthoracic echocardiography in patients undergoing urgent abdominal surgery due to peritonitis.

* To demonstrate that patient management based on extended hemodynamic monitoring by focused echocardiography results in improved survival, reduced incidence of hemodynamic instability during perioperative period.

* To compare an amount of administrated of intravenous fluids in both groups.

The investigators hypothesize that focused echocardiography monitoring will result in more administrated intravenous fluids during perioperative period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
131
Inclusion Criteria
  • Age more than 18 years old.
  • Patients undergoing urgent abdominal surgery due to diffuse peritonitis.
  • SOFA score >2.
  • Patients who sign an agreement to participate in the study.
Exclusion Criteria
  • Younger than 18 years old.
  • Known pregnancy.
  • Unconscious patients or those who do not agree to participate in the study.
  • Contraindication to central venous or arterial catheterization.
  • Patients who were already treated in ICU because of sepsis or septic shock before this surgery.
  • Known chronic renal failure.
  • Re-laparotomy.
  • Peritonitis due to acute mesenteric ischaemia, thrombosis or trauma.
  • Dying patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Focussed echocardiography groupFocused assessed echocardiographyThe extended cardiac monitoring by focused assessed transthoracic echocardiography is applied.
Primary Outcome Measures
NameTimeMethod
Inpatient mortality in both treatment arms.30 days intra-hospital mortality

Comparison of 30 days intra-hospital mortality in both arms.

Secondary Outcome Measures
NameTimeMethod
Comparison of fluid management in both arms (from hospitalisation to the surgery, during the surgery, after the surgery up to 24 hours).up to 24 hours

Comparison of tow fluids management strategies. Usual monitoring group - fluid management based on fluid responsiveness based by clinical sings. FATE group - fluid management based on focused transthoracic echocardiography data.

Number of ICU-Free days.up to 30 days

To compare ICU free days in both groups.

Comparison of incidence of severe hypotension MAP <65 mmHg after anaesthesia induction in both arms.1-5 minutes after anaesthesia induction.

To evaluate the incidence of severe hypotension after anesthesia induction (1 - 5 minutes after induction) in both groups.

Comparison of septic shock incidence in both arms.up to 30 days

To compare the manifestation of septic shock (hemodynamics instability not responding to fluid administration, which requires norepinephrine infusion to maintain MAP ≥ 65 mmHg);

Trial Locations

Locations (1)

Lithuanian university of health sciencies

🇱🇹

Kaunas, A. Mickeviciaus Street 9, Lithuania

© Copyright 2025. All Rights Reserved by MedPath